DYNAVAX TECHNOLOGIES CORPORATION AMENDED AND RESTATED 2004 NON-EMPLOYEE DIRECTOR OPTION PROGRAM AND AMENDED AND RESTATED 2005 NON-EMPLOYEE DIRECTOR CASH COMPENSATION PROGRAM EFFECTIVE APRIL 14, 2005 AMENDED February 5, 2015 (REVISION VERSION 6.0) ARTICLE I ESTABLISHMENT AND PURPOSE OF THE PROGRAM

EX-10.35 2 dvax-ex1035_20141231134.htm EX-10.35

 

 

 

Exhibit 10.35

 

DYNAVAX TECHNOLOGIES CORPORATION

AMENDED AND RESTATED 2004 NON-EMPLOYEE DIRECTOR OPTION PROGRAM

AND

AMENDED AND RESTATED 2005 NON-EMPLOYEE DIRECTOR CASH COMPENSATION PROGRAM

 

EFFECTIVE APRIL 14, 2005

AMENDED February 5, 2015

(REVISION VERSION 6.0)

 

ARTICLE I

ESTABLISHMENT AND PURPOSE OF THE PROGRAM

 

1.1     Establishment of Program

 

The Dynavax Technologies Corporation 2004 Non-Employee Director Option Program, as revised herein, including the Non-Employee Director Cash Compensation Program (collectively, the “Director Program”) is adopted pursuant to the Dynavax Technologies Corporation 2011 Equity Incentive Plan (the “2011 Plan”), in addition to the terms and conditions set forth below, is subject to the provisions of the Plan.

 

1.2     Purpose of Program

 

The purpose of the Director Program is to enhance the ability of the Company to attract and retain directors who are not Employees (“Non-Employee Directors”) through an Option and Cash Compensation program.

 

1.3     Effective Date of the Program

 

The Director Program is effective as of the Registration Date, and as revised on February 5, 2015.

 

ARTICLE II

DEFINITIONS

 

Capitalized terms in this Director Program, unless otherwise defined herein, have the meaning given to them in the Plan.

 

ARTICLE III

OPTION TERMS

 

3.1     Date of Grant and Number of Shares

 

Effective April 14, 2005, a Non-Qualified Stock Option to purchase 15,000 shares of Common Stock shall be granted (the “Initial Grant”) to each Non-Employee Director and 25,000 shares shall be granted to the Non-Employee Chairman of the Board (the “Initial Grant”), and such Initial Grant to be made to Non-Employee Directors elected or appointed to the Board upon the date each such Non-Employee Director first becomes a Non-Employee Director.

 

 

1

 

 

 


 

 

 

 

 

 

In addition, immediately following each annual meeting of the Company’s stockholders, commencing with the annual meeting of the Company’s stockholders in 2012, each Non-Employee Director who continues as a Non-Employee Director following such annual meeting shall be granted a Non-Qualified Stock Option to purchase 7,500 shares of Common Stock (a “Subsequent Grant”). Based on the Non-Employee Director’s election date, the first subsequent grant shall be pro-rated as follows:

 

Service Period from Election Date

Option Grant Schedule

More than 10 up to 12 months

100% of grant (7,500 shares)

More than 7 months, but less than 10

75% of grant (5,625 shares)

More than 4 months, but less than 7

50% of grant (3,750 shares)

More than 1 month, but less than 4

25% of grant (1,875 shares)

 

Each such Subsequent Grant shall be made on the date of the annual stockholders’ meeting in question.

 

3.2     Vesting

 

Each Initial Grant of Common Stock subject to the Option under the Director Program shall vest twenty-five percent (25%) twelve (12) months after the grant date and an additional twenty-five percent (25%) of the shares of Common Stock subject to the Option shall vest on each yearly anniversary of the grant date thereafter, such that the Option will be fully exercisable four (4) years after its date of grant.

 

Each Subsequent Grant under the Director Program will vest and become exercisable as to all of the shares of Common Stock subject to the Option twelve (12) months after the grant date.

 

3.3     Exercise Price

 

The exercise price per share of Common Stock of each Initial Grant and Subsequent Grant shall be one hundred percent (100%) of the Fair Market Value per share on the date of grant.

 

3.4     Corporate Transaction/Change in Control

 

Each Option under the Director Program shall be subject to the provisions of Section 9 of the 2011 Plan relating to the exercise or termination of the Option in the event of a Corporate Transaction or a Change in Control.

 

3.5     Other Terms

 

The Administrator (the “Dynavax Board of Directors”) of the Plan shall determine the remaining terms and conditions of the Options awarded under the Program.

 

ARTICLE IV

CASH COMPENSATION TERMS

 

4.1     Annual Fees

 

Each Non-Employee Director currently on the Company’s board, or elected in 2012 and thereafter, shall receive an annual retainer fee of $40,000. The Chairman of the Board shall receive an annual retainer fee of $65,000. Such annual retainer fees will be paid in quarterly installments at the end of each fiscal quarter where such person is an active director of the board (“active director” requires attendance at 75% of the annually scheduled board meetings) and is inclusive of 5 scheduled board meetings.  

 

2

 

 

 


 

 

 

 

 

 

4.2     [Intentionally Removed]

 

 

4.3     Committee Meeting Fees

 

The Chairman of the Audit Committee shall receive an annual retainer of $20,000. Each member of the audit committee shall receive an annual retainer of $7,500.

 

The Chairman of the Compensation Committee shall receive an annual retainer of $15,000. Each member of the compensation committee shall receive an annual retainer of $7,000.

 

The Chairman of the Nominating and Governance Committee shall receive an annual retainer of $10,000. Each member of the nominating committee shall receive an annual retainer of $5,000.

 

Such annual retainer fees will be paid quarterly at the end of each fiscal quarter where such person is an active Chairman or member of the Committee and an Active Director.

 

4.4     Travel and Related Costs

 

Reasonable travel and related costs associated with attending Board and committee meetings shall be reimbursed. The Board member needs to submit proper documentation for reimbursement.

 

3